The Immunological Contribution of a Novel Metabolism-Related Signature to the Prognosis and Anti-Tumor Immunity in Cervical Cancer

SIMPLE SUMMARY: Cervical cancer is the most commonly diagnosed gynecological malignant carcinoma worldwide. It is crucial to develop reliable prognostic models to predict clinical outcomes and identify patients who will benefit from different treatment strategies. In current study, we identified a r...

Descripción completa

Detalles Bibliográficos
Autores principales: Yu, Sihui, Li, Xi, Ma, Mingjun, Yang, Rui, Zhang, Jiawen, Wu, Sufang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9139200/
https://www.ncbi.nlm.nih.gov/pubmed/35626004
http://dx.doi.org/10.3390/cancers14102399

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9139200/
https://www.ncbi.nlm.nih.gov/pubmed/35626004
http://dx.doi.org/10.3390/cancers14102399

Ejemplares similares